IFNG and cancer: We found that IGF2BP3 was expressed differently in different immune subtypes (C1: wound healing, C2: IFN-gamma dominant, C3: inflammatory, C4: lymphocyte depleted, C5: immunologically quiet, C6: TGF-b dominant) of 29 cancer types.